Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
(KERX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Auryxia
Ferric pyrophosphate citrate
2014-09-05
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Losartan
neoplasms
,
melanoma
Glucosamine
ankylosing spondylitis
,
rheumatoid arthritis
,
arthritis
,
spondylarthritis
,
spondylitis
Perifosine
recurrence
,
brain neoplasms
,
glioblastoma
,
glioma
,
astrocytoma
,
oligodendroglioma
,
neoplasms
Sulodexide
covid-19
,
chronic renal insufficiency
,
kidney diseases
,
venous insufficiency
,
thrombosis
,
post-acute covid-19 syndrome
Aspartame
renal insufficiency
,
delayed graft function
,
hereditary angioedemas
,
angioedema
Corticorelin
rheumatoid arthritis
,
arthritis
,
healthy volunteers/patients
,
sepsis
,
staphylococcal infections
,
staphylococcus aureus
,
chronic renal insufficiency
,
chronic kidney failure
,
renal insufficiency
,
anemia
,
kidney diseases
,
nasal polyps
,
asthma
,
eosinophilia
,
polyps
,
pulmonary eosinophilia
Docetaxol
non-small-cell lung carcinoma
,
adenocarcinoma
,
squamous cell carcinoma
,
large cell carcinoma
Taxane
breast neoplasms
,
neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use